Abstract: A process is claimed for the enantioselective epoxidation of ?,?-unsaturated ketones, in which a compound of the general formula I, is reacted with an oxidizing agent to form ?,?-epoxy ketones of the general formula II, in which R1, R2, R3 are as defined above. The ?,?-epoxy ketones of the general formula II can be obtained in good yields and outstanding enantioselectivities from ?,?-unsaturated ketones of the general formula I by epoxidation with hydrogen peroxide in the presence of a chiral catalyst, such as amino compounds and their acid addition salts.

Abstract: A continuous epoxidation process for the production of high purity propylene oxide by the reaction of propylene with an oxidant that is a per-acid, such as peracetic acid (PAA), in a reactive distillation (RD) column. The RD column provides excellent heat integration and temperature control, and the process has the advantage of lower investment cost for capital equipment. The process operates at mild temperatures and pressures. A ferric acetylacetonate homogeneous catalyst and/or stabilizer may be included as part of the PAA feed to the process to increase PAA conversion and selectivity to propylene oxide. A pre-reactor can be incorporated upstream of the RD column to increase the residence time at lower temperatures to enhance productivity.

Abstract: A novel process for producing a polyfunctional epoxy monomer is provided that facilitates separation of an aqueous layer catalyst from a reaction solution and has satisfactory hydrogen peroxide efficiency by reacting an aqueous hydrogen peroxide solution with a polyolefin without using an organic solvent and under mild conditions. The process in the present invention is a process for producing a corresponding epoxy compound by reacting an organic compound having a carbon-carbon double bond with hydrogen peroxide present in an aqueous hydrogen peroxide solution to epoxidate the double bond, wherein a tungsten compound and tertiary amine are used as reaction catalysts.

Abstract: A process for the production of liquid epoxy resins, including: contacting a polyhydric phenol and an epihalohydrin in the presence of an ionic catalyst to form a halohydrin intermediate reaction product; concurrently: reacting a portion of the halohydrin intermediate reaction product with an alkali hydroxide to form a solid salt suspended in a liquid mixture including a dehydrohalogenated product and unreacted halohydrin intermediate, wherein the alkali hydroxide is used at less than a stoichiometric amount; and removing water and epihalohydrin as a vapor from the reacting mixture; separating the solid salt from the liquid mixture; reacting at least a portion of the unreacted halohydrin intermediate with an alkali hydroxide in the presence of water to form an organic mixture including an epoxy resin and unreacted epihalohydrin and an aqueous solution including a salt; separating the aqueous mixture from the organic mixture; and separating the unreacted epihalohydrin from the liquid epoxy resin.

Abstract: To provide a method of producing acrylic acid which enables low energy-consumption production of acrylic acid from glycerin mixtures including glycerin and one or more compound selected from the group consisting of fatty acids, fatty acid salts, glycerides, fatty acid esters, alkali compounds and alkali compound salts. The method of producing acrylic acid according to the present invention includes the steps of obtaining an acrolein mixture by causing a dehydration reaction to a glycerin mixture; and obtaining an acrylic acid mixture by causing an oxidation reaction to the acrolein mixture; and recovering acrylic acid from the acrylic acid mixture.

Abstract: An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet.

Abstract: What is described is a process for obtaining maleic anhydride by distillation from a solution of maleic anhydride in a high-boiling absorbent which has been obtained by gas phase oxidation of a hydrocarbon and at least partial absorption of the oxidation products into the absorbent, by i) introducing the solution into the side of a feed column with a rectifying section disposed above the feed point and a stripping section disposed below the feed point, ii) providing an upper combining column which communicates with the upper end of the rectifying section and a lower combining column which communicates with the lower end of the stripping section, iii) providing a draw column which communicates with the upper combining column and the lower combining column, iv) drawing maleic anhydride off as a side draw from the draw column, and drawing off compounds having a lower boiling point than maleic anhydride at the top of the upper combining column and the high-boiling absorbent at the bottom of the lower combining c

Abstract: The invention is a process for epoxidizing an olefin with hydrogen and oxygen in a solvent comprising acetonitrile in the presence of an quinone-acid salt and a catalyst comprising a titanium zeolite and a noble metal. The process results in higher productivity and improved selectivity to propylene oxide from hydrogen and oxygen, as compared to processes that use only a quinone.

Abstract: A method for the purification or recovery of lactide rich streams by the combination of a suspension-based melt crystallization process with a subsequent separation of the pure lactide crystals in a wash column is disclosed.

Abstract: The present invention relates to a process for the preparation of (2S,3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamides, and their use in the preparation of HCV inhibitors and cathepsin inhibitors.

Abstract: The invention relates to the (stereoselective) hydrogenation of carbon-carbon double bonds in compounds having at least one such bond, e.g., isoprenoids, non-cyclic sesquiterpenes, tocomonoenols, tocodienols, tocotrienols or derivatives thereof, as well as to the (stereoselective) hydrogenation of parts/extracts of plant oils containing such tocotrienols or derivatives thereof, in the presence of a chiral Ir complex as the catalyst, whereby preferably one stereoisomer is manufactured in an excess.

Abstract: Described herein is a process in which acetic acid is produced by ethane oxidation. One byproduct of the ethane oxidation is water, which is commonly removed from the process in the same stream as the acetic acid process. As described herein, the ethane oxidation reactor effluent is processed in a predehydration tower so as to separately recover water, acetic acid, and a gas stream for recycle back to the ethane oxidation reactor.

Abstract: A stabilized nano-Fe6-iron-crown ether complex is formed by preparing a solution of an iron salt and an olygomer crown compound in dialkylamine or diethylamine. Sodium tetrahydroboron (NaBH4) and dialkylamine or ethylendiamine are added at a temperature of 0-10° C. The mixture is heated to room temperature and boiled, thereby converting the formed iron (II)-borhydride complex (Fe(BH4)2) to a crown ether—iron-hydride complex [CWFe06]·(2H)6. At higher temperature this last complex is converted to the Fe06-crown nanocomposite complex.

Abstract: Process for producing a chlorohydrin by reaction between a multihydroxylated-aliphatic hydrocarbon, an ester of a multihydroxylated-aliphatic hydrocarbon, or a mixture thereof, and a chlorinating agent, according to which the multihydroxylated-aliphatic hydrocarbon, the ester of a multihydroxylated-aliphatic hydrocarbon, or the mixture thereof used contains at least one solid or dissolved metal salt, the process comprising a separation operation to remove at least part of the metal salt.

Abstract: The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the BETA2 adrenergic receptor.

Abstract: A novel epoxy compound represented by the following formula and a method for producing the same are provided: wherein R1 and R2 are members selected from the group consisting of hydrogen, aliphatic hydrocarbon group having 1 to 4 carbon atoms, alicyclic hydrocarbon group having 3 to 6 carbon atoms, aromatic hydrocarbon group having 6 to 10 carbon atoms, halogen atom, ether group, ester group, acyl group and nitro group, n is an integer of 1 to 4, and m is an integer of 1 to 5.

Abstract: The present invention relates to compounds being esters of 5-aminolevulinic acids or pharmaceutically acceptable salts thereof, including compounds of formula (I) R22N—CH2COCH2—CH2CO—OR1 (wherein R1 may represent alkyl optionally substituted by hydroxy, alkoxy, acyloxy, alkoxycarbonyloxy, amino, aryl, oxo or fluoro groups and optionally interrupted by oxygen, nitrogen, sulphur or phosphorus atoms; and R2 represents a hydrogen atom or a group R1, and both R2 groups may be the identical or different), and their use in diagnosis and photochemotherapy of disorders or abnormalities of external or internal surfaces of the body, and products and kits for performing the invention.

Abstract: The present invention relates to a novel process for preparing alkyl polycarboxylates from an aqueous solution of an ammonium salt of the polycarboxylic acid by reactive distillation, and to a process for hydrogenating the alkyl carboxylates prepared in this way.

Abstract: A new purification technique for alkylene oxides is described. The technique is safer than previously reported methods and does not require cooling of the purification vessel. In a solution of a high-boiling point solvent and butyllithium, an alkylene oxide is added and allowed to react at ambient temperature. The impurities readily react with the butyllithium while the alkylene oxide does not. The low-boiling alkylene oxide is then easily distilled out of the high-boiling point solvent as a pure material ready for use in controlled polymerization reactions.

Abstract: A method of purifying a cyclic ester, comprising: mixing a co-distillated liquid comprising a cyclic ester produced by heating depolymerization of a hydroxycarboxylic acid oligomer in the presence of a depolymerization solvent and the depolymerization solvent with an organic solvent for washing which is mutually soluble with the depolymerization solvent and has a lower boiling point than the cyclic ester; subjecting the resultant mixture liquid to liquid-liquid separation into an organic solvent phase containing the depolymerization solvent and a cyclic ester phase containing the organic solvent; and then evaporating the organic solvent from the cyclic ester phase containing the organic solvent to recover the cyclic ester containing a reduced amount of the depolymerization solvent.